Analysis

Research Topics
Research Categories
Life Sciences and Public Health
  • Biotechnology
  • Biowarfare
  • COVID 19
  • Life Sciences
  • Public Health
  • Genomics
Technology and POLICY
  • Data Protection
  • High Tech Geopolitics
  • Platform Regulation
  • Information Disorder
  • Networked Protests
  • Artificial Intelligence
  • Social Media
  • Technology
Foreign Affairs, Defence and Security
  • Defence
  • China
  • Foreign Policy
  • National Security
  • Nuclear Strategy
  • Europe
  • West Asia
  • Space Policy
  • Space Strategy
  • USA
  • Energy
  • Communications
  • Indo-Pacific
  • India's Neighbourhood
  • Maritime
  • Subsurface
  • World Order
  • Military
  • PLA
  • Semiconductors
Public Affairs and Governance
  • Economy
  • Governance
  • Markets
  • Public Finance
  • Labour
  • Investment
  • Policy Discussion
  • Banking
  • Regulation
  • Ideas for India
  • COVID 19

Vaccinate people in areas worst affected by COVID’s second wave

This article was first published The Mint. You can read the original piece here. In the past month, we have learnt two things about the pandemic. First, that relaxed behaviour by previously better-protected populations across the country is causing a surge in new coronavirus infections; and second, that the speed...

Vaccine diplomacy post-Covid-19

Vaccine diplomacy is state-led action of leveraging vaccine expertise for furthering foreign policy goals. These goals can range from maintaining ties between nations, burnishing an international reputation, or developing influence within a region. A robust framework can aid in the identification of vaccine diplomacy opportunities and allow India to quickly...

Private sector can be govt’s useful ally in Covid vaccination, not an adversary

Despite being the second-fastest country to vaccinate over 10 million people and currently having the third-highest number of people vaccinated against Covid-19, it is fair to say that India’s vaccination programme has gotten off to a slow start. At around 300,000 per day, the current vaccination rate is only a...

The History of Vaccine Diplomacy

The Beginning, #1 In fields of diplomacy, vaccine diplomacy is a relatively novel subset, structured around using medicines, trained personnel, and scientific knowledge to support and further foreign policy. Of all the forms of diplomacy, this is surely the one that is most inextricably linked to kindness and courage, for...

COVID-19 vaccine diplomacy: India’s opportunity to regain leadership in the neighbourhood

COVID-19 vaccine diplomacy: India’s opportunity to regain leadership in the neighbourhood By Pranathi Rao In early 2020, India responded to COVID-19 with a strict lockdown, mask mandates, and a broad shutdown of schools and recreational centers. The disease burden- as the country with the second highest number of total COVID-19...

Why India will not see a big second wave of Covid-19

There will not be a significant second wave of Covid-19 in India. Last August, using a Cynically Optimistic Back Of The Envelope, or COBOTE, calculation, I estimated that Covid-19 will end its epidemic phase in India by January 2021. Karthik Shashidhar, my collaborator, used the curve-fitting technique to predict that...

Takshashila Discussion SlideDoc — India’s Opportunity to Displace China in Global Supply Chains

Download the Discussion SlideDoc in PDF This assessment proposes a mix of two approaches that the Indian government should adopt in order to attract investments from companies looking to exit China. The first, a geostrategy-led approach, entails working with like-minded partners, particularly focussing on sectors with national security implications. The...

DCGI’s Covaxin ‘approval’ is political jumla. It reinforces idea of Modi’s Atmanirbhar Bharat

Other than to the highly credulous, it is pretty obvious that the Drugs Controller General of India’s ‘approval’ for Bharat Biotech’s indigenous vaccine candidate, Covaxin, was announced for extra-scientific reasons. It has neither completed Phase 3 clinical trials, nor has the safety and efficacy data been published. In fact, the...

No matter what Bharat Biotech says, Covaxin is just not ready for approvals

Bharat Biotech got an approval for its COVID-19 vaccine and along with it came a lot of flak from critics who believe that the process was rushed for no valid reason. Dr Krishna Ella, the founder and chairman of Bharat Biotech, retaliated blaming everyone from the media to rival vaccine makers,...

Testing and Tracing: Case for a Relook

The Drug Controller General of India has given emergency approvals to vaccine candidates being manufactured in India. The Government of India is also keen on a nationwide rollout through a mass vaccination campaign.  While the focus should be on ensuring an effective and equitable strategy for vaccine deployment, India must...
1 2 3 4 5 14